-
14161por Meyerson, Beth E., Lawrence, Carrie A., Cope, Summer Dawn, Levin, Steven, Thomas, Christopher, Eldridge, Lori Ann, Coles, Haley B., Vadiei, Nina, Kennedy, Amy“…Retail syringe sales at pharmacies remain an important, yet barrier-laden, element of a comprehensive public health response to reduce HIV and hepatitis C among PWID. Future studies should test multilevel evidence-based interventions to decrease staff discrimination and stigma and increase syringe sales.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14162por O’Connor, Siobhan M., Mixson-Hayden, Tonya, Ganova-Raeva, Lilia, Djibo, Djeneba Audrey, Brown, Matthew, Xia, Guo-Liang, Kamili, Saleem, Jacobs, Marni, Dong, Maxia, Thomas, Anne G., Bulterys, Marc, Hale, Braden“…BACKGROUND: Guyana expanded its HIV response in 2005 but the epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections has not been characterized. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14163por Ohashi, Kazuki, Ishikawa, Toru, Hoshii, Asami, Hokari, Tamaki, Suzuki, Mitsuyuki, Mitobe, Yuta, Yamada, Etsuko, Abeywickrama, Hansani Madushika, Kikuchi, Yuko, Noguchi, Hirohito, Hirosawa, Hiroshi, Koyama, Yu“…The most common etiology of liver disease was hepatitis C (38%). The frequency of living alone and low exercise habit was significantly high, and sarcopenia was more obvious in elderly patients with low PA than in those with high PA. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14164por Surial, Bernard, Cavassini, Matthias, Calmy, Alexandra, Fehr, Jan, Stöckle, Marcel, Bernasconi, Enos, Roth, Bianca, Fux, Christoph A., Kovari, Helen, Furrer, Hansjakob, Rauch, Andri, Wandeler, Gilles“…In contrast, patients with a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based single-pill regimen (0.11, 0.09–0.13), those treated in non-tertiary care centers (0.56, 0.46–0.70), as well as those with CD4 cell counts below 500/μL (0.77, 0.66–0.90) and with chronic hepatitis C infection (0.66, 0.54–0.80) were most likely to stay on TDF. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14165por Shanyinde, Milensu, Girardi, Enrico, Puoti, Massimo, De Luca, Andrea, Sighinolfi, Laura, Caterina, Uberti Foppa, Caramello, Pietro, Lampe, Fiona C., D’Arminio Monforte, Antonella, Cozzi-Lepri, Alessandro“…We aimed at assessing the usefulness of routine data collected on alcohol consumption in predicting risk of severe liver disease (SLD) among people living with HIV (PLWHIV) with or without hepatitis C infection seen for routine clinical care in Italy. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14166“…BACKGROUND: It is well documented that Egypt has the highest prevalence of hepatitis C virus (HCV) infection in the world. The recent development of highly effective direct acting antiviral drugs (DAAs), has opened the possibility of treating and curing HCV infection in the Egyptian population on a large scale. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14167por Rosenthal, Elana S, Nussdorf, Laura, D’Amore, Aaron, Brokus, Christopher, Silk, Rachel, Eyasu, Rahwa, Mathur, Poonam, Bijole, Phyllis, Jones, Miriam, Kier, Randy, Sternberg, David, Masur, Henry, Kottilil, Shyam, Kattakuzhy, Sarah“…BACKGROUND: People who inject drugs (PWID) have significant morbidity and mortality associated with hepatitis C (HCV); however, harms associated with ongoing injecting drug use (IDU)—such as opioid overdose—may pose a more imminent risk, and often are not addressed as part of HCV treatment. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14168por Ogunremi, Toju, Defalco, Katherine, Lynn Johnston, B, Boucoiran, Isabelle, Cividino, Maureen, Cleghorn, Blaine, Ann Isinger, Melody, Mark Joffe, A, Mazzulli, Tony, Robert, Yves, Vearncombe, Mary, Wong, David K, Wong, Jason, Dunn, Kathy, Henry, Bonnie“…METHODS: A total of six systematic reviews (1995–2016) were conducted to inform the risk of transmission of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) from infected HCWs to patients and the infectivity of each virus related to source serum viral load. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14169por Dewage Hansa Ramanayake, Ranpati“…Serum samples were screened for hepatitis B surface antigen (HBsAg), antibodies and antigens to hepatitis C virus (HCV), human immunodeficiency virus (HIV) 1 and 2 and Treponema pallidum using commercially available immunochromatic based kits. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14170“…Modifiable risk factors present in both patients were active smoking, history of substance use disorder, chronic pulmonary disease, depression and hepatitis C antibody positivity. Both patients had CD4 counts >600 cells/mm(3). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14171por Marks, Laura, Schwarz, Evan, Liss, David, Satish, Munigala, Warren, David K, Stephen, Liang, Durkin, Michael“…Infection with HIV (2.8%), and hepatitis B (3%), and hepatitis C (67%) were similar between groups. Continuation of medications for OUD was associated with increased completion of parenteral antibiotics (odds ratio 2.11; 95% confidence interval 1.70–2.63). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14172“…There is current interest in expanding OTC diagnostics (FDA approved for HIV and hepatitis C) to other infectious diseases such as GAS pharyngitis. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14173por Vuylsteke, Bea, Reyniers, Thijs, De Baetselier, Irith, Nöstlinger, Christiana, Crucitti, Tania, Buyze, Jozefien, Kenyon, Chris, Wouters, Kristien, Laga, Marie“…We did not detect a significant change in N. gonorrhoeae/C. trachomatis incidence over time. The incidence of hepatitis C was 2.9 per 100 person‐years. CONCLUSIONS: PrEP is an effective and well adopted HIV prevention tool for MSM in Belgium. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14174por Ng’wamkai, Gilbert, Msigwa, Kalista V., Chengula, Damas, Mgaya, Frank, Chuma, Clotilda, Msemwa, Betrand, Silago, Vitus, Majigo, Mtebe, Mshana, Stephen E., Mirambo, Mariam M.“…METHODS: Between February and May 2018, a total of 499 pregnant women were enrolled and tested for Human immunodeficiency virus (HIV), Herpes simplex virus-2 (HSV-2), Hepatitis B virus (HBV) and Hepatitis C virus (HCV) using rapid immunochromatographic tests and for syphilis using non-treponemal and treponemal antibody test. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14175por Aydin, Yucel, Kurt, Ramazan, Song, Kyoungsub, Lin, Dong, Osman, Hanadi, Youngquist, Brady, Scott, John W., Shores, Nathan J., Thevenot, Paul, Cohen, Ari, Dash, Srikanta“…Hepatitis C virus (HCV) infection compromises the natural defense mechanisms of the liver leading to a progressive end stage disease such as cirrhosis and hepatocellular carcinoma (HCC). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14176por Fontana, Robert J., Lens, Sabela, McPherson, Stuart, Elkhashab, Magdy, Ankoma-Sey, Victor, Bondin, Mark, dos Santos, Ana Gabriela Pires, Xue, Zhenyi, Trinh, Roger, Porcalla, Ariel, Zeuzem, Stefan“…INTRODUCTION: The presence or absence of cirrhosis in patients with chronic hepatitis C virus (HCV) infection influences the type and duration of antiviral therapy. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14177por Zuckerman, Autumn D., Douglas, Andrew, Whelchel, Kristen, Choi, Leena, DeClercq, Joshua, Chastain, Cody A.“…INTRODUCTION: Sustained virologic response (SVR) rates in patients with hepatitis C virus (HCV) monoinfection and human immunodeficiency virus (HIV)/HCV coinfection treated with direct acting antiviral (DAA) therapy are similar in clinical trials. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14178por Behzadi, Mohammad Amin, Leyva-Grado, Victor Hugo, Namayandeh, Mandana, Ziyaeyan, Atoosa, Feyznezhad, Roya, Dorzaban, Hedayat, Jamalidoust, Marzieh, Ziyaeyan, Mazyar“…The prevalence of anti-hepatitis C virus (HCV) antibodies was 0.7% (4/562). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14179por Schecke, Henrike, Lea, Toby, Bohn, Annette, Köhler, Thorsten, Sander, Dirk, Scherbaum, Norbert, Deimel, Daniel“…Drug use in sexual settings is correlated with sexual practices associated with the acquisition and transmission of sexually transmitted infections, including HIV and hepatitis C. Adverse mental health outcomes are often reported at higher rates among MSM who use methamphetamine. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14180por Salvetat, N., Van der Laan, S., Vire, B., Chimienti, F., Cleophax, S., Bronowicki, J. P., Doffoel, M., Bourlière, M., Schwan, R., Lang, J. P., Pujol, J. F., Weissmann, D.“…Treatment-emergent depression is a common complication in patients with chronic hepatitis C virus (HCV) infection undergoing antiviral combination therapy with IFN-α and ribavirin. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto